Luis
Montuenga Badía
Catedrático de Universidad
Luis Montuenga Badía-rekin lankidetzan egindako argitalpenak (21)
2024
2022
-
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
Cancer Letters, Vol. 529, pp. 70-84
-
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity
The Journal of experimental medicine, Vol. 219, Núm. 12
-
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
DMM Disease Models and Mechanisms, Vol. 15, Núm. 1
2021
-
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer
Translational Research, Vol. 233, pp. 77-91
-
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337
2020
-
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Nature cancer, Vol. 1, Núm. 1, pp. 75-85
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
Epistatic oncogenic interactions determine cancer susceptibility to immunotherapy
Cancer Discovery, Vol. 8, Núm. 7, pp. 794-796
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2017
-
Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer
Cancer Discovery, Vol. 7, Núm. 12, pp. 1420-1435
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer
Molecular Oncology, Vol. 10, Núm. 9, pp. 1437-1449
-
Successful immunotherapy against a transplantable mouse squamous lung carcinoma with anti-PD-1 and anti-CD137 monoclonal antibodies
Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. 524-536
2014
-
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
British Journal of Cancer, Vol. 110, Núm. 6, pp. 1545-1551
2013
-
Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer
Journal of the National Cancer Institute, Vol. 105, Núm. 18, pp. 1385-1393
-
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC
International Journal of Cancer, Vol. 132, Núm. 9, pp. 1986-1995
2012
-
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression
Journal of Immunology, Vol. 189, Núm. 9, pp. 4674-4683
2008
2007
-
Lymphangiogenesis and lung cancer
Journal of Thoracic Oncology, Vol. 2, Núm. 5, pp. 384-386